跳至主要内容
临床试验/EUCTR2017-002349-30-BE
EUCTR2017-002349-30-BE进行中(未招募)1 期

Effect of codeine on pharyngeal and esophageal motility in healthy subjects: a double-blind, placebo-controlled, randomized, cross-over study

TARGID, KU Leuven0 个研究点目标入组 20 人开始时间: 2017年6月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • age > 18 and < 60 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - they are older than 60 years old and younger than 18 years;
  • - they are taking medication altering the GI motility;
  • - they have severely decreased kidney function;
  • - they have severely decreased liver function;
  • - they have severe heart disease, for example heart failure, angina, history of myocardial infarction, arrythmia;
  • - they have severe lung disease (i.e. severe chronic obstructive pulmonary disease, pulmonary fibrosis, cystic fibrosis);
  • - have prostate disorders;
  • - they have severe psychiatric illness or neurological illness;
  • - they have any gastrointestinal disease, upper GI symptoms or GI surgery;
  • - they have history of head and neck surgery;
  • - they are women that are pregnant or breastfeeding (details on menstrual cycle, date of last intercourse will be asked upon first visit by an experienced doctor);
  • - they have a history of drug abuse;
  • - they have known side-effects/allergic reactions when taking codeine/morphine.

研究者

发起方
TARGID, KU Leuven

相似试验